<DOC>
	<DOC>NCT02604654</DOC>
	<brief_summary>The purpose of the prospective study is to evaluate the effectiveness and safety of Yiqitongluo granule in the treatment of stroke with qi-deficiency and blood-stasis in more than sixy hospitals all over China.</brief_summary>
	<brief_title>Effectiveness and Safety of Yiqitongluo Granule for Stroke</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<criteria>mild and moderate ischemic stroke patient with 425 NIHSS score stable patients within 1 week to 3 months sign informed consent before study CT shows cerebral hemorrhage disease: such as hemorrhagic stroke, epidural hematoma, intracranial hematoma, ventricular hemorrhage, and subarachnoid hemorrhage severe disturbance of consciousness dysphagia TIA hemorrhagic diathesis patient with malignant tumor whose expected lifetime is less than 3 months allergic constitution gestation period, lactation period, woman with the possibility or plan of pregnancy those who participated in other clinical trials within 3 months or taking part in other clinical trials</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>